治験レーダーAI | ||
|---|---|---|
治験 NCT04489043 (EXPRED)(対象:糖尿病)は状況不明です。詳細は治験レーダーのタイル表示と AI 発見ツールで確認するか、ここで質問してください。 | ||
フィルター基準に一致する試験が1件見つかりました
タイル表示
Exercise, Prediabetes and Diabetes After Renal Transplantation. (EXPRED) 60 運動療法
治験(臨床試験)の詳細は主に英語で提供されていますが、治験レーダーAIがサポートします!「治験解説」をクリックして、選択した言語で試験情報を表示し、議論してください。
治験番号 NCT04489043 (EXPRED) は 介入研究 臨床試験 で、糖尿病 に関するものです。現在は 状況不明 で、2019年9月5日 から開始しています。60 名の参加者 の募集が計画されています。この試験は Hospital Universitario de Canarias によって主導され、2021年10月1日 に完了予定です。ClinicalTrials.gov からの最新更新日は 2020年7月28日 です。
概要
This study is designed to evaluate the feasibility of exercise to reverse prediabetes after transplantation to prevent Posttransplantation Diabetes Mellitus (PTDM).
詳細説明
The hypothesis of the study is that exercise will promote the reversibility to normal glucose metabolism in patients with prediabetes and eventually reduce the incidence of PTDM in renal transplant. The main objective of the study is to induce the reversibility of prediabetes by means of exercise. Additionally, the secondary objectives are: (a) to evaluate the compliance of exercise (b) improvements in metabolic risk...もっと見る
公式タイトル
Exercise, Prediabetes and Diabetes After Renal Transplantation.
疾患名
糖尿病刊行物
この臨床試験について発表された科学記事と研究論文:その他の研究識別子
- EXPRED
NCT番号
開始日
2019-09-05
最終更新日
2020-07-28
終了予定日
2021-10-01
目標参加者数
60
試験の種類
介入研究
治験の相・段階
該当なし
状況
状況不明
キーワード
PreDiabetes
Exercise
Late post transplant Diabetes Mellitus (PTDM)
Renal transplantation
Exercise
Late post transplant Diabetes Mellitus (PTDM)
Renal transplantation
主目的
予防
割付方法
該当なし
介入モデル
単一群割当
盲検化
なし(非盲検)
群(アーム)/介入
| 参加グループ/群 | 介入/治療法 |
|---|---|
実験的Exercise and healthy life style recommendations A planned exercise programme to test the impact of this treatment. An Oral Glucose Tolerant Test (OGTT) at intermediate time points in order to increase the frequency and duration of aerobic exercise and eventually to add anaerobic/resistance training. | Exercise and healthy lifestyle recommendations In the present study, renal transplant patients with proven prediabetes will do a planned exercise programme to test the impact of this treatment on the reversibility of prediabetes. Thus, the persistance of recurrency of prediabetes assessed by an Oral Glucose Tolerant Test (OGTT) at intermediate time points (3, 6 and 9 months) will be checked in order to increase the frequency and duration of aerobic exercise and e...もっと見る |
主要評価項目
副次評価項目
| 評価指標 | 指標の説明 | 時間枠 |
|---|---|---|
Oral glucose tolerance test (OGTT) | After a 10-12 h overnight fast, a standard 75-g OGTT with samples taken at 0 min (glucose-insulin) and 120 minutes (glucose) will be performed at screening-baseline and after 3,6,9,12 months. Patients must be clinically stable without conditions that could induce transient hyperglycaemia or insulin resistance, i.e. infections, acute rejection, renal failure or cardiovascular disease. The presence of any of these conditions postponed the test for at least 3 months after full recovery. Also, serum and urinary samples will be taken and storage at -80 degrees. | Baseline and 3 months-12 months, every 3 months |
| 評価指標 | 指標の説明 | 時間枠 |
|---|---|---|
Compliance | To ensure compliance, the following measures will be implemented: (a) contact by phone one time per week (at the end of the week) in the first 3 months up to the end of the study, (b) individual interview every month to reinforce lifestyle changes and follow all recommended in the exercise prescription; (c) the use of a gadget (xiaomi mi band) to see daily routines of patients and every training prescription; this analyses the time, frequency, burned calories, velocity and distance, among others, to reach the established goal by the physiotherapist. | Baseline and 3 months-12 months, every 3 months |
Analitics | To evaluate the improvements in metabolic risk factors profile: obesity, triglycerides, blood pressure and HDL cholesterol.hemogram (hematocrit, haemoglobin, white blood count), biochemist tests: creatinine, HbA1c, total, LDL and HDL cholesterol, triglycerides, uric acid, hepatic enzymes (ASAT, ALAT), levels of immunosuppression, albumin, creatinine, albuminuria, proteinuria in an isolated urinary samples. | Baseline and 3 months-12 months, every 3 months |
Test the reversibility of prediabetes | There is a n exercise programme to test the impact of this treatment on the reversibility of prediabetes. Thus, the persistance of recurrency of prediabetes assessed by an OGTT at intermediate time points (3, 6 and 9 months) will be checked in order to increase the frequency and duration of aerobic exercise and eventually to add anaerobic/resistance training. | Baseline and 3 months-12 months, every 3 months |
Cardiorrespiratory fitness test | Cardiopulmonary exercise testing (CPTE) will be performed in a treadmill while collecting expired gases analysis41. The test will begin at low work rates and gradually increased42 until indications to stop are perceived or volitional exhaustion. The workloads selected for participants should be designed with the aim to reach the maximal effort (peak exercise) in the 8-12 minutes interval43. During CPET maximal oxygen uptake (VO2max) is measured, the stronger predictor of CV risk. It is generally expressed as relative (ml/kg/min)44. | Baseline and 3 months-12 months, every 3 months |
Anthropometric measures | At baseline and at 3, 6, 9, 12 months: weight in kilograms, height in meters, waist circumference, hip circumference, will be measured. Also, BMI Body mass index (BMI): weight in kilograms divided by the square of the height in meters. The cutt-off values are the standards by the WHO97. | Baseline and 3 months-12 months, every 3 months |
適格基準
対象年齢
成人, 高齢者
試験の最低年齢
18 Years
対象性別
全て
- Age > 18 years old.
- Renal transplantation: beyond 6-12 months after transplantation with stable renal function
- IFG: 100-125 mg/dl and IGT 140-199 mg/dl.
- Ability or capacity to perform exercise.
- Clinical conditions that preclude the treatment with exercise i.e. clinical instability: active infection, cancer, acute cardiovascular disease, advanced renal disease, pulmonar hypertension, chronic obstructive pulmonary disease, severe reumatological disorders, arthrosis, arthritis limb amputation, etc.
- Inability to understand the protocol.
- Severe psychological disease.
- PTDM.
- Diabetes before transplantation.
試験中央連絡先
連絡先: Raul Morales Febles, +34 922678115, [email protected]
1 1カ国の場所
S/C de TEnerife
UICEC, San Cristóbal de La Laguna, S/C de TEnerife, 38320, Spain
Raul Morales Febles, Master, 連絡先, +34 922678115, [email protected]
Esteban Porrini, MD., PhD, 連絡先, +34 922678116, [email protected]
募集中